---
layout: post
title: "台高端疫苗三期临床试验将获世卫资助"
date: 2021-10-27T09:38:27.642Z
author: 联合早报
from: https://www.zaobao.com/realtime/china/story20211027-1207491
tags: [ 联合早报 ]
categories: [ 联合早报 ]
---
<!--1635348900000-->
[台高端疫苗三期临床试验将获世卫资助](https://www.zaobao.com/realtime/china/story20211027-1207491)
------

<div>
<p>台湾高端疫苗获选参与世界卫生组织（WHO）的“团结试验疫苗”（Solidarity Trial Vaccines）计划，这意味着该疫苗的正统三期临床试验将获得世卫资助。</p><p>据台湾《经济日报》报道，高端疫苗昨天（26日）公告，获选参与世卫及哥伦比亚、马里、菲律宾三个国家的团结试验疫苗计划。</p><p>高端疫苗副总经理李思贤今（27）天说，这项临床试验是采用传统的多国三期临床试验，将分为对照组与疫苗组，验证高端疫苗的保护力。</p><section id="imu"><div id="dfp-ad-imu1">        </div></section><p>对于高端疫苗而言，这项临床试验的重要意义是，所有试验费用将由WHO及三个国家共同分担，高端疫苗仅需负责疫苗生产及运输费用。</p><p>李思贤说，若是由高端疫苗全额负担三期临床试验，估计至少新台币50亿元至100亿元（2.42亿至4.85亿新元）。</p><p>另外，自今年年中以来，台卫福部食药署公布EUA（紧急授权许可）标准之后，高端疫苗应否采“免疫桥接”方式进行临床试验，一度引发不同专家争论。</p><div id="innity-in-post"></div><div id="dfp-ad-midarticlespecial">        </div><p>对此，李思贤表示，不论是对于巴拉圭正在进行、或者正向欧盟申请的临床试验，高端仍会继续采“免疫桥接”临床试验争取更多国家通过EUA。<br> </p>            <a href="https://subscribe.sph.com.sg/promotions/zbpe-3-months-99-cents-promotion/?utm_campaign=zbpe399&utm_medium=sph-publication&utm_source=zb&utm_content=subscribelink-free-endofarticle" target="_blank"><img class="view-desktop lazyload  " data-src="https://static.zaobao.com/s3fs-public/freemium_images/20210901/paywall_desktop-zbpe399_2.png?dHEiGouxxZpWwWTJE04dyGyUN74JOU2z" alt style="width:100%;" pinger-seen="true" src="https://static.zaobao.com/s3fs-public/freemium_images/20210901/paywall_desktop-zbpe399_2.png?dHEiGouxxZpWwWTJE04dyGyUN74JOU2z" referrerpolicy="no-referrer"></a>      <a href="https://subscribe.sph.com.sg/promotions/zbpe-3-months-99-cents-promotion/?utm_campaign=zbpe399&utm_medium=sph-publication&utm_source=zb&utm_content=subscribelink-free-endofarticle" target="_blank"><img class="view-mobile lazyload " data-src="https://static.zaobao.com/s3fs-public/freemium_images/20210901/paywall_mobile-zbpe399_2.png?qZnBcIGCJvPR8A2IAZOZuOxdoGZDatiI" alt pinger-seen="true" src="https://static.zaobao.com/s3fs-public/freemium_images/20210901/paywall_mobile-zbpe399_2.png?qZnBcIGCJvPR8A2IAZOZuOxdoGZDatiI" referrerpolicy="no-referrer"></a>
</div>
